1. Home
  2. FEAM vs XGN Comparison

FEAM vs XGN Comparison

Compare FEAM & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 5E Advanced Materials Inc.

FEAM

5E Advanced Materials Inc.

HOLD

Current Price

$3.90

Market Cap

89.1M

Sector

Industrials

ML Signal

HOLD

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$7.20

Market Cap

253.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FEAM
XGN
Founded
2016
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.1M
253.9M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
FEAM
XGN
Price
$3.90
$7.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$8.13
$13.67
AVG Volume (30 Days)
74.8K
312.4K
Earning Date
11-13-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$63,599,000.00
Revenue This Year
N/A
$22.15
Revenue Next Year
$500.00
$15.26
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.08
52 Week Low
$2.82
$2.67
52 Week High
$24.84
$12.23

Technical Indicators

Market Signals
Indicator
FEAM
XGN
Relative Strength Index (RSI) 44.83 31.11
Support Level $3.89 $7.01
Resistance Level $4.21 $7.33
Average True Range (ATR) 0.29 0.32
MACD 0.04 0.07
Stochastic Oscillator 60.53 27.14

Price Performance

Historical Comparison
FEAM
XGN

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

About XGN Exagen Inc.

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Share on Social Networks: